{"id":69019,"date":"2026-06-29T15:05:31","date_gmt":"2026-06-29T07:05:31","guid":{"rendered":"https:\/\/flcube.com\/?p=69019"},"modified":"2026-06-29T15:05:32","modified_gmt":"2026-06-29T07:05:32","slug":"chinas-cde-unveils-108th-batch-of-reference-preparations-for-generic-drug-evaluation-adds-28-new-drugs","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=69019","title":{"rendered":"China&#8217;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">China&#8217;s <strong>Center for Drug Evaluation (CDE)<\/strong> has released the <strong>108th batch of reference preparations<\/strong> for <strong>generic quality and consistency evaluation (GQCE)<\/strong> purposes, introducing <strong>28 new drugs<\/strong> and <strong>18 additional specifications<\/strong> to the draft list. The announcement opens a public consultation period through <strong>July 9, 2026<\/strong>, while simultaneously revealing that <strong>10 drug applications failed to meet review standards<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-reference-preparation-updates\" class=\"wp-block-heading\">Reference Preparation Updates<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Category<\/th><th>Count<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>New drugs added<\/strong><\/td><td>28<\/td><td>Added to reference preparation list<\/td><\/tr><tr><td><strong>Additional specifications<\/strong><\/td><td>18<\/td><td>New dosage forms or strengths<\/td><\/tr><tr><td><strong>Failed applications<\/strong><\/td><td>10<\/td><td>Did not pass CDE review criteria<\/td><\/tr><tr><td><strong>Public feedback deadline<\/strong><\/td><td>July 9, 2026<\/td><td>Final date for stakeholder comments<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-regulatory-context-amp-process\" class=\"wp-block-heading\">Regulatory Context &amp; Process<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Program:<\/strong> Generic Quality and Consistency Evaluation (GQCE)<\/li>\n\n\n\n<li><strong>Authority:<\/strong> Center for Drug Evaluation (CDE), National Medical Products Administration<\/li>\n\n\n\n<li><strong>Batch:<\/strong> 108th official reference preparation selection<\/li>\n\n\n\n<li><strong>Purpose:<\/strong> Establish bioequivalence standards for generic drug manufacturers<\/li>\n\n\n\n<li><strong>Stakeholder Engagement:<\/strong> 10-day public consultation period for industry feedback<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-implications\" class=\"wp-block-heading\">Market Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Generic Competition:<\/strong> New reference preparations enable additional manufacturers to develop competing generic versions, potentially reducing drug costs<\/li>\n\n\n\n<li><strong>Quality Standards:<\/strong> The GQCE program ensures generic drugs demonstrate equivalent efficacy and safety to originator products<\/li>\n\n\n\n<li><strong>Regulatory Efficiency:<\/strong> Streamlined reference preparation selection accelerates generic drug approval timelines<\/li>\n\n\n\n<li><strong>Industry Impact:<\/strong> Failed applications indicate CDE&#8217;s rigorous evaluation standards, maintaining high quality benchmarks for market entry<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The CDE&#8217;s systematic approach to reference preparation selection supports China&#8217;s broader pharmaceutical reform goals of improving drug quality, controlling healthcare costs, and fostering domestic generic drug development capabilities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking information regarding regulatory processes. Actual implementation timelines and market impacts may vary based on final CDE decisions and industry response during the consultation period.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[4],"tags":[102,31,103,14],"class_list":["post-69019","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-cde","tag-generic-drugs","tag-gqce-testing","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China&#039;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for generic quality and consistency evaluation (GQCE) purposes, introducing 28 new drugs and 18 additional specifications to the draft list. The announcement opens a public consultation period through July 9, 2026, while simultaneously revealing that 10 drug applications failed to meet review standards.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=69019\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China&#039;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs\" \/>\n<meta property=\"og:description\" content=\"China&#039;s Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for generic quality and consistency evaluation (GQCE) purposes, introducing 28 new drugs and 18 additional specifications to the draft list. The announcement opens a public consultation period through July 9, 2026, while simultaneously revealing that 10 drug applications failed to meet review standards.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=69019\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T07:05:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T07:05:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69019#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69019\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China&#8217;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs\",\"datePublished\":\"2026-06-29T07:05:31+00:00\",\"dateModified\":\"2026-06-29T07:05:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69019\"},\"wordCount\":278,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"CDE\",\"Generic drugs\",\"GQCE testing\",\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69019#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69019\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=69019\",\"name\":\"China's CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-29T07:05:31+00:00\",\"dateModified\":\"2026-06-29T07:05:32+00:00\",\"description\":\"China's Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for generic quality and consistency evaluation (GQCE) purposes, introducing 28 new drugs and 18 additional specifications to the draft list. The announcement opens a public consultation period through July 9, 2026, while simultaneously revealing that 10 drug applications failed to meet review standards.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69019#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69019\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69019#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China&#8217;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China's CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs - Insight, China&#039;s Pharmaceutical Industry","description":"China's Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for generic quality and consistency evaluation (GQCE) purposes, introducing 28 new drugs and 18 additional specifications to the draft list. The announcement opens a public consultation period through July 9, 2026, while simultaneously revealing that 10 drug applications failed to meet review standards.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=69019","og_locale":"en_US","og_type":"article","og_title":"China's CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs","og_description":"China's Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for generic quality and consistency evaluation (GQCE) purposes, introducing 28 new drugs and 18 additional specifications to the draft list. The announcement opens a public consultation period through July 9, 2026, while simultaneously revealing that 10 drug applications failed to meet review standards.","og_url":"https:\/\/flcube.com\/?p=69019","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-29T07:05:31+00:00","article_modified_time":"2026-06-29T07:05:32+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=69019#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=69019"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China&#8217;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs","datePublished":"2026-06-29T07:05:31+00:00","dateModified":"2026-06-29T07:05:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=69019"},"wordCount":278,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["CDE","Generic drugs","GQCE testing","NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=69019#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=69019","url":"https:\/\/flcube.com\/?p=69019","name":"China's CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-29T07:05:31+00:00","dateModified":"2026-06-29T07:05:32+00:00","description":"China's Center for Drug Evaluation (CDE) has released the 108th batch of reference preparations for generic quality and consistency evaluation (GQCE) purposes, introducing 28 new drugs and 18 additional specifications to the draft list. The announcement opens a public consultation period through July 9, 2026, while simultaneously revealing that 10 drug applications failed to meet review standards.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=69019#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=69019"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=69019#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China&#8217;s CDE Unveils 108th Batch of Reference Preparations for Generic Drug Evaluation, Adds 28 New Drugs"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=69019"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69019\/revisions"}],"predecessor-version":[{"id":69020,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69019\/revisions\/69020"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=69019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=69019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=69019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}